Impact of Biomarker-based Design Strategies on the Risk of False-Positive Findings in Targeted Therapy Evaluation.

Tat-Thang VoAlexandre Vivot Raphael Porcher

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)

The drug-biomarker coevaluation based on a series of independent enrichment trials can result in a high risk of false-positive findings. CVASD with some appropriate adjustments can be a good alternative to overcome this multiplicity issue.

Keyphrases

emergency department